Side-by-side comparison of AI visibility scores, market position, and capabilities
Lagos B2B pharmaceutical marketplace connecting 5,000+ African pharmacies to GSK/Pfizer/AstraZeneca with 24-hour delivery and inventory financing; $12M QED Investors Series A with 7x revenue growth.
Remedial Health is a Lagos-based B2B health technology company digitizing pharmaceutical procurement for African pharmacies and hospitals — operating an e-commerce marketplace connecting 5,000+ pharmacies and healthcare facilities with 300+ pharmaceutical manufacturers including GSK, Pfizer, and AstraZeneca, providing access to 8,000+ SKUs, 24-hour delivery across Nigeria, and inventory financing that enables pharmacies to stock products without full upfront capital. Founded in 2021 and backed with $16.4 million raised including a $12 million Series A led by QED Investors in March 2024, Remedial Health achieved 7x revenue growth in 10 months while tripling its client base since late 2023.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.